RPL3 and colorectal carcinoma: Using two-dimensional (2D) and three-dimensional(3D) models of 5-FU-resistant CRC cells stably silenced for uL3, weinvestigated the effect of a novel therapeutic strategy by combiningβ-carotene and 5-FU using nanoparticles (NPs) as a drug deliverysystem.